• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MUC1 在泌尿生殖系统癌症中的研究进展。

Research progress of MUC1 in genitourinary cancers.

机构信息

Department of Urology, Affiliated Zhongda Hospital of Southeast University, No. 87 Dingjiaqiao, Gulou District, Nanjing, 210009, Jiangsu, China.

Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.

出版信息

Cell Mol Biol Lett. 2024 Nov 3;29(1):135. doi: 10.1186/s11658-024-00654-x.

DOI:10.1186/s11658-024-00654-x
PMID:39491020
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/
Abstract

MUC1 is a highly glycosylated transmembrane protein with a high molecular weight. It plays a role in lubricating and protecting mucosal epithelium, participates in epithelial cell renewal and differentiation, and regulates cell adhesion, signal transduction, and immune response. MUC1 is expressed in both normal and malignant epithelial cells, and plays an important role in the diagnosis, prognosis prediction and clinical monitoring of a variety of tumors and is expected to be a new therapeutic target. This article reviews the structural features, expression regulation mechanism, and research progress of MUC1 in the development of genitourinary cancers and its clinical applications.

摘要

黏蛋白 1 是一种高度糖基化的跨膜蛋白,具有高分子量。它在润滑和保护黏膜上皮中发挥作用,参与上皮细胞更新和分化,并调节细胞黏附、信号转导和免疫反应。黏蛋白 1 在正常和恶性上皮细胞中均有表达,在多种肿瘤的诊断、预后预测和临床监测中发挥重要作用,有望成为新的治疗靶点。本文综述了黏蛋白 1 在泌尿生殖系统癌症发生发展中的结构特征、表达调控机制及研究进展及其在临床上的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91a8/11533421/29750700d588/11658_2024_654_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91a8/11533421/815c75f24a6d/11658_2024_654_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91a8/11533421/b1a5822f6ef1/11658_2024_654_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91a8/11533421/30dd845c512b/11658_2024_654_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91a8/11533421/29750700d588/11658_2024_654_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91a8/11533421/815c75f24a6d/11658_2024_654_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91a8/11533421/b1a5822f6ef1/11658_2024_654_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91a8/11533421/30dd845c512b/11658_2024_654_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91a8/11533421/29750700d588/11658_2024_654_Fig4_HTML.jpg

相似文献

1
Research progress of MUC1 in genitourinary cancers.MUC1 在泌尿生殖系统癌症中的研究进展。
Cell Mol Biol Lett. 2024 Nov 3;29(1):135. doi: 10.1186/s11658-024-00654-x.
2
MUC1: a multifaceted oncoprotein with a key role in cancer progression.黏蛋白1:一种在癌症进展中起关键作用的多面癌蛋白。
Trends Mol Med. 2014 Jun;20(6):332-42. doi: 10.1016/j.molmed.2014.02.007. Epub 2014 Mar 22.
3
Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression.Lewis(y) 抗原通过刺激 MUC1 表达促进上皮性卵巢癌的进展。
Int J Mol Med. 2017 Aug;40(2):293-302. doi: 10.3892/ijmm.2017.3009. Epub 2017 Jun 2.
4
MUC1: a novel metabolic master regulator.MUC1:一种新型的代谢主调控因子。
Biochim Biophys Acta. 2014 Apr;1845(2):126-35. doi: 10.1016/j.bbcan.2014.01.001. Epub 2014 Jan 11.
5
MUC1 in hematological malignancies.血液系统恶性肿瘤中的MUC1
Leuk Lymphoma. 2016 Nov;57(11):2489-98. doi: 10.1080/10428194.2016.1195500. Epub 2016 Jun 27.
6
MUC1: Structure, Function, and Clinic Application in Epithelial Cancers.MUC1:在上皮性癌症中的结构、功能与临床应用。
Int J Mol Sci. 2021 Jun 18;22(12):6567. doi: 10.3390/ijms22126567.
7
Molecular crosstalk between MUC1 and STAT3 influences the anti-proliferative effect of Napabucasin in epithelial cancers.MUC1 和 STAT3 之间的分子串扰影响 Napabucasin 在上皮性癌症中的抗增殖作用。
Sci Rep. 2024 Feb 7;14(1):3178. doi: 10.1038/s41598-024-53549-4.
8
MUC1 regulates AKT signaling pathway by upregulating EGFR expression in ovarian cancer cells.MUC1通过上调卵巢癌细胞中EGFR的表达来调节AKT信号通路。
Pathol Res Pract. 2021 Aug;224:153509. doi: 10.1016/j.prp.2021.153509. Epub 2021 Jun 4.
9
Upregulation of mucin glycoprotein MUC1 in the progression to esophageal adenocarcinoma and therapeutic potential with a targeted photoactive antibody-drug conjugate.黏蛋白糖蛋白MUC1在食管腺癌进展中的上调及靶向光活性抗体-药物偶联物的治疗潜力
Oncotarget. 2017 Apr 11;8(15):25080-25096. doi: 10.18632/oncotarget.15340.
10
MUC1 protein expression in tumor cells regulates transcription of proinflammatory cytokines by forming a complex with nuclear factor-κB p65 and binding to cytokine promoters: importance of extracellular domain.肿瘤细胞中 MUC1 蛋白的表达通过与核因子-κB p65 形成复合物并与细胞因子启动子结合来调节前炎性细胞因子的转录:细胞外结构域的重要性。
J Biol Chem. 2011 Dec 9;286(49):42248-42256. doi: 10.1074/jbc.M111.297630. Epub 2011 Oct 22.

引用本文的文献

1
Glycosylation in cancer: mechanisms, diagnostic markers, and therapeutic applications.癌症中的糖基化:机制、诊断标志物及治疗应用。
Mol Cell Biochem. 2025 May 19. doi: 10.1007/s11010-025-05303-1.

本文引用的文献

1
MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC.MUC1-C是NSCLC中获得性奥希替尼耐药的常见驱动因素。
J Thorac Oncol. 2024 Mar;19(3):434-450. doi: 10.1016/j.jtho.2023.10.017. Epub 2023 Nov 3.
2
MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression.黏蛋白 1 细胞黏附分子-C 通过调节 Set1a 罗盘复合物在癌症进展中与表观遗传重编程交叉,从而影响慢性炎症。
Commun Biol. 2023 Oct 11;6(1):1030. doi: 10.1038/s42003-023-05395-9.
3
Canonical and truncated transglutaminase-2 regulate mucin-1 expression and androgen independency in prostate cancer cell lines.
经典型和截短型转谷氨酰胺酶-2 调节前列腺癌细胞系中黏蛋白-1 的表达和雄激素非依赖性。
Cell Death Dis. 2023 May 9;14(5):317. doi: 10.1038/s41419-023-05818-9.
4
MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation.MUC1 表达通过补体系统激活和免疫浸润调节影响肾细胞癌微环境中的免疫炎症反应。
Int J Mol Sci. 2023 Mar 2;24(5):4814. doi: 10.3390/ijms24054814.
5
The multifaceted role of MUC1 in tumor therapy resistance.MUC1 在肿瘤治疗耐药中的多效性作用。
Clin Exp Med. 2023 Sep;23(5):1441-1474. doi: 10.1007/s10238-022-00978-y. Epub 2022 Dec 23.
6
MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome.MUC1 组织表达及其可溶性形式 CA15-3 可识别出一种具有独特代谢特征和不良临床结局的透明细胞肾细胞癌。
Int J Mol Sci. 2022 Nov 12;23(22):13968. doi: 10.3390/ijms232213968.
7
Phase 1 trial of CV301 in combination with anti-PD-1 therapy in nonsquamous non-small cell lung cancer.CV301 联合抗 PD-1 疗法治疗非鳞状非小细胞肺癌的 1 期临床试验。
Int J Cancer. 2023 Feb 1;152(3):447-457. doi: 10.1002/ijc.34267. Epub 2022 Sep 9.
8
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma.CV301 疫苗联合阿替利珠单抗治疗晚期尿路上皮癌的 II 期临床试验。
Cancer Immunol Immunother. 2023 Mar;72(3):775-782. doi: 10.1007/s00262-022-03274-6. Epub 2022 Aug 23.
9
Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer Progression.癌症干细胞对三阴性乳腺癌进展中 MUC1-C 的成瘾。
Int J Mol Sci. 2022 Jul 26;23(15):8219. doi: 10.3390/ijms23158219.
10
Robot-Assisted Laparoscopic Radical Cystectomy and Modified Y-Shaped Ileal Orthotopic Neobladder Reconstruction.机器人辅助腹腔镜根治性膀胱切除术及改良Y形回肠原位新膀胱重建术
Front Surg. 2022 Jun 1;9:889536. doi: 10.3389/fsurg.2022.889536. eCollection 2022.